Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis
Related Posts
Haywood HB, Ikeaba U, Fonarow GC, Xu H, Selvaraj S, Lewsey SC, Alhanti B, McDermott JJ, Wright J, Vaduganathan M, Greene SJ. Outpatient clinic visits[...]
Srivatsa S, Farkouh EK, Stockwell T, Pike JR, Clay JM, Bey G, Nasir K, Budoff M, Naimi T, Farkouh ME. Reassessing alcohol consumption and cardiovascular[...]
Sharifan A, Fonarow GC. Statistical Misinterpretation of Nonsignificant Results in Diabetes Randomised Clinical Trials. Diabetes Metab Res Rev. 2026 May;42(4):e70179. doi: 10.1002/dmrr.70179. PMID: 42106583.